$546 Million is the total value of Parkman Healthcare Partners LLC's 102 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 38.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BSX | Buy | BOSTON SCIENTIFIC CORP | $31,535,328 | +23.2% | 597,260 | +26.2% | 5.78% | +30.3% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $31,244,145 | +15.1% | 138,328 | +12.5% | 5.72% | +21.7% |
| BDX | Buy | BECTON DICKINSON & CO | $25,323,531 | +14.7% | 97,952 | +17.1% | 4.64% | +21.2% |
| DXCM | Buy | DEXCOM INC | $24,772,829 | +126.5% | 265,518 | +211.9% | 4.54% | +139.4% |
| COO | Buy | COOPER COS INC | $20,772,731 | +35.0% | 65,321 | +62.8% | 3.81% | +42.7% |
| ABC | Buy | CENCORA INC | $17,429,195 | +5.0% | 96,845 | +12.3% | 3.19% | +11.0% |
| THC | Sell | TENET HEALTHCARE CORP | $14,900,430 | -27.9% | 226,141 | -11.0% | 2.73% | -23.8% |
| HCA | New | HCA HEALTHCARE INC | $13,814,237 | – | 56,160 | +100.0% | 2.53% | – |
| PCVX | Buy | VAXCYTE INC | $12,139,969 | +6.4% | 238,132 | +4.2% | 2.22% | +12.4% |
| IMGN | Sell | IMMUNOGEN INC | $11,393,390 | -28.2% | 717,920 | -14.6% | 2.09% | -24.1% |
| Sell | RXSIGHT INC | $10,635,322 | -25.9% | 381,331 | -23.5% | 1.95% | -21.7% | |
| SDGR | Sell | SCHRODINGER INC | $10,421,849 | -56.7% | 368,654 | -23.6% | 1.91% | -54.3% |
| HUM | Buy | HUMANA INC | $10,368,228 | +107.8% | 21,311 | +91.0% | 1.90% | +119.7% |
| KROS | Buy | KEROS THERAPEUTICS INC | $9,515,383 | -14.4% | 298,475 | +7.8% | 1.74% | -9.5% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $9,432,563 | -28.4% | 83,845 | -40.0% | 1.73% | -24.3% |
| KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $8,855,400 | +115.6% | 509,810 | +74.8% | 1.62% | +127.9% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $8,676,177 | -18.7% | 51,311 | +4.2% | 1.59% | -14.1% |
| CRL | New | CHARLES RIV LABS INTL INC | $8,654,477 | – | 44,160 | +100.0% | 1.59% | – |
| MNKD | Buy | MANNKIND CORP | $8,544,751 | +15.6% | 2,068,947 | +13.9% | 1.57% | +22.2% |
| ZBH | New | ZIMMER BIOMET HOLDINGS INC | $7,967,620 | – | 71,000 | +100.0% | 1.46% | – |
| HAE | Sell | HAEMONETICS CORP MASS | $7,969,216 | -18.7% | 88,962 | -22.7% | 1.46% | -14.0% |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $7,760,598 | – | 15,332 | +100.0% | 1.42% | – |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $7,598,966 | -5.9% | 597,403 | +4.2% | 1.39% | -0.5% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $7,400,559 | -11.7% | 216,644 | -0.5% | 1.36% | -6.7% |
| Buy | ARCELLX INC | $7,300,934 | +18.3% | 203,482 | +4.2% | 1.34% | +25.0% | |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $7,235,056 | +15.2% | 159,503 | +4.2% | 1.33% | +21.8% |
| VRNA | Buy | VERONA PHARMA PLCsponsored ads | $6,812,308 | -19.6% | 417,933 | +4.2% | 1.25% | -15.0% |
| PODD | Sell | INSULET CORP | $6,702,567 | -60.0% | 42,025 | -27.6% | 1.23% | -57.7% |
| ANIP | Sell | ANI PHARMACEUTICALS INC | $6,491,224 | -30.9% | 111,802 | -35.9% | 1.19% | -27.0% |
| AKRO | Buy | AKERO THERAPEUTICS INC | $5,872,692 | +259.4% | 116,107 | +231.7% | 1.08% | +280.2% |
| DAWN | Buy | DAY ONE BIOPHARMACEUTICALS I | $5,722,826 | +11.9% | 466,408 | +8.9% | 1.05% | +18.4% |
| ETNB | Buy | 89BIO INC | $5,613,258 | -15.1% | 363,553 | +4.2% | 1.03% | -10.2% |
| AMGN | New | AMGEN INC | $5,375,200 | – | 20,000 | +100.0% | 0.98% | – |
| INSP | Buy | INSPIRE MED SYS INC | $5,342,600 | +13.7% | 26,923 | +86.1% | 0.98% | +20.3% |
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $5,162,796 | +129.7% | 577,494 | +294.7% | 0.95% | +142.6% |
| VCYT | Buy | VERACYTE INC | $5,043,722 | -6.6% | 225,872 | +6.6% | 0.92% | -1.3% |
| APLT | New | APPLIED THERAPEUTICS INC | $4,357,500 | – | 1,750,000 | +100.0% | 0.80% | – |
| STRO | Buy | SUTRO BIOPHARMA INC | $4,102,123 | -22.9% | 1,182,168 | +3.3% | 0.75% | -18.4% |
| CGEM | Buy | CULLINAN ONCOLOGY INC | $3,970,642 | +6.4% | 438,745 | +26.5% | 0.73% | +12.5% |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $3,809,402 | -33.4% | 138,172 | -27.3% | 0.70% | -29.6% |
| CSTL | Buy | CASTLE BIOSCIENCES INC | $3,793,359 | +86.8% | 224,592 | +51.7% | 0.70% | +97.4% |
| SILK | Sell | SILK RD MED INC | $3,737,622 | -62.6% | 249,341 | -18.9% | 0.68% | -60.5% |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $3,681,707 | +51.0% | 205,109 | +70.9% | 0.68% | +59.6% |
| CTLT | Sell | CATALENT INC | $3,671,812 | -40.0% | 80,646 | -42.9% | 0.67% | -36.6% |
| IDYA | Buy | IDEAYA BIOSCIENCES INC | $3,580,273 | +19.6% | 132,701 | +4.2% | 0.66% | +26.4% |
| LNTH | Sell | LANTHEUS HLDGS INC | $3,466,288 | -83.2% | 49,889 | -79.7% | 0.64% | -82.2% |
| CVRX | Buy | CVRX INC | $3,369,560 | +55.0% | 222,120 | +57.8% | 0.62% | +63.7% |
| SIBN | Buy | SI-BONE INC | $3,293,177 | -12.1% | 155,046 | +11.6% | 0.60% | -7.2% |
| INSM | New | INSMED INC | $3,156,250 | – | 125,000 | +100.0% | 0.58% | – |
| MRUS | Buy | MERUS N V | $3,082,731 | +72.5% | 130,735 | +92.6% | 0.56% | +82.3% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $3,084,745 | -29.2% | 212,448 | +2.0% | 0.56% | -25.3% |
| Sell | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $3,037,701 | -25.5% | 53,293 | -33.4% | 0.56% | -21.2% | |
| NEO | Buy | NEOGENOMICS INC | $3,023,488 | -20.2% | 245,812 | +4.2% | 0.55% | -15.7% |
| CRNX | New | CRINETICS PHARMACEUTICALS IN | $2,974,000 | – | 100,000 | +100.0% | 0.54% | – |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $2,970,207 | -25.5% | 60,530 | +4.2% | 0.54% | -21.3% |
| New | SOLENO THERAPEUTICS INC | $2,951,000 | – | 100,000 | +100.0% | 0.54% | – | |
| PFMT | Sell | PERFORMANT FINL CORP | $2,936,610 | -24.8% | 1,299,385 | -10.2% | 0.54% | -20.5% |
| EVH | Sell | EVOLENT HEALTH INCcl a | $2,813,404 | -22.3% | 103,320 | -13.5% | 0.52% | -17.8% |
| EW | New | EDWARDS LIFESCIENCES CORP | $2,771,200 | – | 40,000 | +100.0% | 0.51% | – |
| EWTX | Buy | EDGEWISE THERAPEUTICS INC | $2,712,078 | -23.0% | 473,312 | +4.2% | 0.50% | -18.5% |
| BBIO | New | BRIDGEBIO PHARMA INC | $2,637,000 | – | 100,000 | +100.0% | 0.48% | – |
| BCYC | Sell | BICYCLE THERAPEUTICS PLCsponsored ads | $2,465,465 | -43.9% | 122,721 | -28.8% | 0.45% | -40.7% |
| AKYA | Buy | AKOYA BIOSCIENCES INC | $2,444,147 | -29.8% | 525,623 | +11.6% | 0.45% | -25.7% |
| LYRA | Buy | LYRA THERAPEUTICS INC | $2,443,969 | -0.9% | 625,056 | +4.2% | 0.45% | +4.9% |
| Buy | DISC MEDICINE INC | $2,445,685 | +10.2% | 52,058 | +4.1% | 0.45% | +16.4% | |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $2,412,793 | +0.7% | 115,777 | +15.8% | 0.44% | +6.5% |
| Buy | NEWAMSTERDAM PHARMA COMPANYordinary shares | $2,303,472 | -19.0% | 249,024 | +4.2% | 0.42% | -14.4% | |
| NTRA | Sell | NATERA INC | $2,245,732 | -38.5% | 50,751 | -32.4% | 0.41% | -35.1% |
| QTRX | Buy | QUANTERIX CORP | $2,092,141 | +85.0% | 77,087 | +53.7% | 0.38% | +95.4% |
| ABOS | New | ACUMEN PHARMACEUTICALS INC | $2,074,228 | – | 499,814 | +100.0% | 0.38% | – |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $2,055,580 | +27.3% | 65,050 | +4.2% | 0.38% | +34.6% |
| ARVN | Buy | ARVINAS INC | $2,044,858 | -17.6% | 104,117 | +4.1% | 0.38% | -12.8% |
| URGN | New | UROGEN PHARMA LTD | $2,035,807 | – | 145,311 | +100.0% | 0.37% | – |
| LBPH | Buy | LONGBOARD PHARMACEUTICALS IN | $1,979,121 | -21.1% | 355,957 | +4.2% | 0.36% | -16.6% |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $1,957,130 | -34.0% | 1,997,071 | -6.3% | 0.36% | -30.2% |
| AUGX | New | AUGMEDIX INC | $1,936,822 | – | 376,082 | +100.0% | 0.36% | – |
| SLN | Buy | SILENCE THERAPEUTICS PLCads | $1,894,072 | +86.1% | 192,879 | +4.2% | 0.35% | +97.2% |
| COGT | Buy | COGENT BIOSCIENCES INC | $1,887,961 | -14.2% | 193,637 | +4.2% | 0.35% | -9.2% |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $1,758,343 | -59.4% | 210,580 | -35.3% | 0.32% | -57.1% |
| TGTX | Sell | TG THERAPEUTICS INC | $1,749,907 | -68.1% | 209,319 | -5.1% | 0.32% | -66.2% |
| CDMO | Buy | AVID BIOSERVICES INC | $1,752,187 | -29.5% | 185,613 | +4.3% | 0.32% | -25.5% |
| AMAM | New | AMBRX BIOPHARMA INCsponsored ads | $1,725,000 | – | 150,000 | +100.0% | 0.32% | – |
| MORF | New | MORPHIC HLDG INC | $1,718,250 | – | 75,000 | +100.0% | 0.32% | – |
| New | TANGO THERAPEUTICS INC | $1,530,459 | – | 135,920 | +100.0% | 0.28% | – | |
| New | STRUCTURE THERAPEUTICS INCsponsored ads | $1,512,600 | – | 30,000 | +100.0% | 0.28% | – | |
| BDTX | Buy | BLACK DIAMOND THERAPEUTICS I | $1,494,085 | -40.8% | 520,587 | +4.1% | 0.27% | -37.4% |
| FLDM | New | STANDARD BIOTOOLS INC | $1,450,000 | – | 500,000 | +100.0% | 0.27% | – |
| TELA | Buy | TELA BIO INC | $1,333,800 | -17.2% | 166,725 | +4.8% | 0.24% | -12.5% |
| LXRX | Sell | LEXICON PHARMACEUTICALS INC | $1,238,690 | -59.3% | 1,136,413 | -14.6% | 0.23% | -57.0% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $971,042 | -51.6% | 141,758 | -26.8% | 0.18% | -48.9% |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $963,000 | – | 100,000 | +100.0% | 0.18% | – |
| XFOR | Sell | X4 PHARMACEUTICALS INC | $872,000 | -88.1% | 800,000 | -78.8% | 0.16% | -87.4% |
| IMUX | Buy | IMMUNIC INC | $826,884 | -39.0% | 562,506 | +4.2% | 0.15% | -35.3% |
| LQDA | Sell | LIQUIDIA CORPORATION | $743,384 | -66.3% | 117,253 | -58.3% | 0.14% | -64.5% |
| INZY | Buy | INOZYME PHARMA INC | $738,763 | -21.4% | 175,896 | +4.2% | 0.14% | -17.2% |
| Sell | ASLAN PHARMACEUTICALS LTDspon ads new | $700,753 | -62.1% | 372,741 | -26.4% | 0.13% | -60.1% | |
| ETON | New | ETON PHARMACEUTICALS INC | $688,050 | – | 165,000 | +100.0% | 0.13% | – |
| TKNO | Buy | ALPHA TEKNOVA INC | $652,151 | +38.5% | 233,746 | +32.6% | 0.12% | +45.1% |
| CUTR | New | CUTERA INC | $602,000 | – | 100,000 | +100.0% | 0.11% | – |
| AFIB | Buy | ACUTUS MED INC | $553,201 | -18.2% | 794,145 | +4.2% | 0.10% | -13.7% |
| VYGR | Buy | VOYAGER THERAPEUTICS INC | $467,496 | -29.5% | 60,322 | +4.2% | 0.09% | -25.2% |
| TERN | Sell | TERNS PHARMACEUTICALS INC | $209,892 | -76.6% | 41,728 | -59.3% | 0.04% | -75.5% |
| CDTX | Exit | CIDARA THERAPEUTICS INC | $0 | – | -136,011 | -100.0% | -0.03% | – |
| Exit | MINERALYS THERAPEUTICS INC | $0 | – | -11,658 | -100.0% | -0.03% | – | |
| SVRA | Exit | SAVARA INC | $0 | – | -206,607 | -100.0% | -0.11% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -187,500 | -100.0% | -0.13% | – |
| GRTX | Exit | GALERA THERAPEUTICS INC | $0 | – | -540,847 | -100.0% | -0.29% | – |
| Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -171,075 | -100.0% | -0.32% | – | |
| AXGN | Exit | AXOGEN INC | $0 | – | -260,858 | -100.0% | -0.41% | – |
| SWAV | Exit | SHOCKWAVE MED INC | $0 | – | -10,076 | -100.0% | -0.50% | – |
| KRMD | Exit | KORU MEDICAL SYSTEMS INC | $0 | – | -899,063 | -100.0% | -0.54% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -70,033 | -100.0% | -0.57% | – |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -216,868 | -100.0% | -0.71% | – |
| MMS | Exit | MAXIMUS INC | $0 | – | -50,381 | -100.0% | -0.74% | – |
| SGEN | Exit | SEAGEN INC | $0 | – | -22,602 | -100.0% | -0.75% | – |
| WAT | Exit | WATERS CORP | $0 | – | -40,688 | -100.0% | -1.88% | – |
| DHR | Exit | DANAHER CORPORATION | $0 | – | -60,696 | -100.0% | -2.52% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 16 | Q3 2023 | 6.3% |
| ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
| XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
| NATERA INC | 16 | Q3 2023 | 3.4% |
| AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
| SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
| REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
| MANNKIND CORP | 15 | Q3 2023 | 1.6% |
| IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
| INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.